TABLE 4: Cryptococcal disease and outcome of patients with or without comorbidities and organ transplantation, regardless of the Cryptococcus species.
| Comorbidity or organ transplantation | P-value* | ||
|---|---|---|---|
| Absent n/% | Present n/% | ||
| Cryptococcus species complex | |||
| C. gattii complex | 5/50 | 7/27 | 0.2474 |
| C. neoformans | 5/50 | 19/73 | |
| Cryptococcosis site | |||
| Meningitis | 9/90 | 12/46 | 0.0245 |
| Cryptococcemia | 1/10 | 8/31 | 0.3921 |
| Pulmonary | 2/20 | 14/54 | 0.1326 |
| Cutaneous | 1/10 | 5/19 | 0.6546 |
| Lymphadenopathy | 0/0 | 1/4 | 1.0 |
| Outcomea | |||
| Cure/improvement | 8/80 | 13/54 | 0.2508 |
| Death | 2/20 | 11/46 | |
| Unknown | 0 | 2 | - |
| Patients - Total | 10/100 | 26/100 | |
Cure/improvement and death rates excluded patients whose outcome was unknown; *statistical analysis.